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Active adult neurogenesis produces new functional neurons, which replace the
lost ones and contribute to brain repair. Promoting neurogenesis may offer a
therapeutic strategy for human diseases associated with neurodegeneration. Here,
we report that endogenous neuronal nitric oxide synthase (nNOS) for neural stem
cells (NSCs) or progenitors positively regulates neurogenesis. nNOS repression exhibits
significantly decreased neuronal differentiation and nNOS upregulation promotes
neurons production from NSCs. Using a quantitative approach, we show that instructive
effect, that is instruction of NSCs to adopt a neuronal fate, contributes to the
favorable effect of endogenous nNOS on neurogenesis. Furthermore, nNOS-mediated
instruction of neuronal fate commitment is predominantly due to the reduction of histone
deacetylase 2 (HDAC2) expression and enzymatic activity. Further investigation will be
needed to test whether HDAC2 can serve as a new target for therapeutic intervention
of neurodegenerative disorders.
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INTRODUCTION
It is now widely accepted that active neurogenesis persists throughout adult life in restricted brain
regions of almost all mammals, including humans (Ming and Song, 2005, 2011; Bergmann et al.,
2015). Adult neurogenesis is known as a process of generating new neurons from neural stem
cells (NSCs), including the proliferation of NSCs or progenitors, fate determination of progenitors,
and the survival, migration, maturation, and integration of new neurons (Braun and Jessberger,
2014; Jin, 2016). Failing or altered neurogenesis can cause a number of neuropsychiatric diseases,
such as Alzheimer’s disease and depression (Ruan et al., 2014). Newborn neurons by replacing the
lost ones may contribute to brain repair. Thus, promoting neurogenesis may represent a potential
therapeutic strategy for the treatment of neuropsychiatric diseases. Many intrinsic and extrinsic
factors, such as epigenetic mechanisms and neurotransmitters (Juliandi et al., 2010; Berg et al.,
2013), can regulate adult neurogenesis under physiological and pathological conditions. However,
the detail cellular and molecular mechanisms that guide adult neurogenesis are not completely
discovered.
Nitric oxide (NO), a free gaseous neurotransmitter, is synthesized by three different isoforms
of nitric oxide synthase (NOS), neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS),
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and inducible NOS (iNOS) (Zhou and Zhu, 2009; Berg et al.,
2013). NO cannot be stored in cells and its function is dependent
on new synthesis by NOS. nNOS, the NOS we focus on, is
mainly expressed in cytoplasm of neurons but also been found
in NSCs and astrocytes (Bredt et al., 1990; Arbones et al., 1996;
Wang et al., 1999). Many studies have demonstrated that nNOS
in adult brains negatively regulates neurogenesis (Packer et al.,
2003; Moreno-Lopez et al., 2004; Luo et al., 2014). We hold
the opinion that the negative effect of nNOS on neurogenesis
in vivo is produced by neuron-derived nNOS because of main
expression of nNOS in neurons but little in NSCs and astrocytes.
Our preliminary data suggest that NSC-derived nNOS opposite
to neuron-derived nNOS is required for neuronal differentiation
(Luo et al., 2010). However, we still do not know whether
NSC-derived nNOS contributes to neuronal fate commitment
or the favorable effect on neuronal differentiation is just due to
the proliferation of NSCs or reduced apoptosis of new neurons.
Furthermore, the detail mechanisms underlying the role of
endogenous nNOS in neurogenesis remain unclear.
Histone deacetylases (HDACs) have been implicated in the
epigenetic regulation of neurogenesis by chromatin structure
modulation (Ma et al., 2010; Jobe et al., 2012). Mammalian
HDACs including HDAC1∼11 and SIRT1∼7 have been classified
into three classes (Marks et al., 2003). Among HDACs, HDAC2
grouped in class I is selectively expressed in neurons but not
in glial lineage cells during NSC differentiation (Juliandi et al.,
2010). HDAC2 has been shown to negatively regulate synaptic
plasticity and affect neurological functions such as regulating
learning and memory (Guan et al., 2009; Kramer, 2009; Nott
et al., 2015). Here, we show that HDAC2 negatively regulates
neuronal fate commitment and mediates the instructive effect of
endogenous nNOS on fate commitment by NSCs to a neuronal
lineage.
MATERIALS AND METHODS
Animals
Homozygous nNOS-deficient mice (B6; 129S4-Nos1tm1Plh,
nNOS−/−) and their wild-type controls of similar genetic
background (B6129SF2, WT) (both from Jackson Laboratories)
were maintained in Model Animal Research Center of Nanjing
University. Adult male (2-month-old) and embryonic ICR mice
(Shanghai Silaike Laboratory Animal) were also used in this
study. All experimental protocols using animals were approved
by the Institutional Animal Care and Use Committee of Nanjing
Medical University.
Cell Culture
Embryonic NSCs were isolated from embryonic day 14 (E14)
mouse cortex as we previously described (Luo et al., 2010), with
minor modifications. Cells were floating cultured in proliferation
medium, DMEM/F12 medium (1:1; Invitrogen) containing
20 ng/ml basic fibroblast growth factor (bFGF; Sigma-Aldrich),
20 ng/ml epidermal growth factor (EGF; Sigma-Aldrich), and
2% B27 supplement (Invitrogen), and passaged every 4–6 days.
Embryonic NSCs of the second to fifth passage were used in this
study.
Adult NSCs were isolated and cultured as previously described
(Luo et al., 2010), with some modifications. In brief, the dentate
gyri of 2-month-old male mice (10 mice were used in each
primary isolation experiment) were dissected and digested with
0.125% trypsin (Invitrogen) at 37◦C for 15 min. Then the
digestion was terminated with DMEM/F12 medium containing
10% fetal bovine serum (FBS; TBD), and serum-free DMEM/F12
medium was used to wash remanent FBS. Finally, cells were
centrifuged and resuspended in proliferation medium, seeded at
1 × 106 cells/ml, and maintained at 37◦C with 5% CO2. Adult
NSCs of the second to fourth passage were used in this study.
NSC Differentiation
Monolayer-cultured NSCs were allowed to differentiate in
differentiation medium (DMEM/F12 medium containing 2% B27
and 0.5% FBS). Cells underwent different treatments and were
fixed at different time points for immunofluorescence label.
For HDAC2 expression and enzymatic activity assay,
neurospheres were planted in differentiation medium in
cell culture dishes coated with polyornithine (10 µg/ml;
Sigma-Aldrich), and were immediately treated with vehicle or
100 µM N5-(1-imino-3-butenyl)-L-ornithine (L-VNIO; Alexis
Biochemicals) for 24 h. Then the protein was extracted.
Cell Proliferation Assay
Cell proliferation was assessed by cell counting for the
neurosphere-cultured NSCs and by bromodeoxyuridine (BrdU)
incorporation for the monolayer-cultured NSCs. For cell
counting, single-cell suspension was seeded at 2 × 104 cells/ml.
Four days later, new-generated neurospheres were dissociated
to single cells and the number of cells was counted on a
hemocytometer. Data were normalized to the percentage of
control.
For BrdU incorporation, NSCs were plated on coverslips
coated with polyornithine and laminin (5 µg/ml; Invitrogen) and
cultured as a monolayer. The cells were treated with 2.5 µM
BrdU (Sigma-Aldrich) during the later 2 days of the 4-day
differentiation, or 10 µM BrdU during the last 2 h of the 24-h
proliferation culture, or 10 µM BrdU for 24 h for identification of
cultured adult NSCs. Then the cultures were fixed in phosphate-
buffered solution (PBS) containing 4% paraformaldehyde for
15 min at room temperature and BrdU+ cells were visualized by
immunofluorescence label.
Immunofluorescence
Fixed cultures were blocked in PBS with 3% goat serum,
0.3% Triton X-100, and 0.1% bovine serum albumin at room
temperature for 1 h, followed by incubation with primary
antibody at 4◦C overnight and then secondary antibody for
2 h at room temperature. The primary antibodies used were
as follows: mouse anti-nestin (1:100; sc-33677; Santa Cruz
Biotechnology), mouse anti-β-III-Tubulin (1:200; MAB1637;
Millipore Bioscience Research Reagents) or mouse anti-glial
fibrillary acidic protein (GFAP; 1:1000; MAB360; Millipore
Bioscience Research Reagents). The fluorescent secondary
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antibody used was goat anti-mouse DyLight488 (1:400; 515-485-
062; Jackson ImmunoReasch). Finally, Hoechst 33258 (Sigma-
Aldrich) was used to label the nuclei.
For BrdU immunofluorescence, fixed membranes were first
ruptured by 0.2% Triton X-100. Then, the cells were denatured
in 2 M HCl (20◦C for 10 min) and rinsed in 0.1 M boric
acid (pH 8.5) for 10 min before blocking. The next steps were
the same to those mentioned above in immunofluorescence.
The primary antibody was mouse anti-BrdU (1:1000; MAB4072;
Millipore Bioscience Research Reagents), and the secondary
antibody was goat anti-mouse Cy3 (1:200; 115-165-003; Jackson
ImmunoReasch).
All these images of immunostained cells were captured with a
fluorescence microscope (Axio Imager; Zeiss). The percentages
of neurons, astrocytes and BrdU-labeled dividing cells were
calculated in 40 high-power fields systematically across the
coverslip. The cells were counted using Image-Pro (Media
Cybernetics).
Cell Apoptosis and Necrosis Assay
Cell apoptosis and necrosis assay kit (Beyotime) was used to
detect dead cells during NSC differentiation. Living cultures were
stained with propidium iodide (PI) which stains dead cells and
Hoechst 33342 which stains live and dead cells for 20 min at 37◦C
and imaged with a fluorescence microscope at 40×.
Quantitative Analysis of Neurogenesis
from NSCs
A mathematical description of neurogenesis was used to analyze
the effect of nNOS from NSCs on neuronal fate as previously
described (Song et al., 2002; Hsieh et al., 2004a), with some
modifications. PIj is the number of dead cells present at the start
of the j day in culture, Nj is the total number of cells present at that
time, δj is the death rate of all cells. δj is given by the equation δj
Nj = PIj+1 – PIj. In addition, nj+1 is the total number of neurons
present at the start of the (j+1) day, and it is given by the equation
nj+1 = nj + βj (Nj-nj) – δjnnj, where βj is the conversion rate of
progenitors to neurons for that day and δjn is the death rate of
neurons. The second term on the right is the number of neurons
generated by conversion of neural progenitors, and the third term
is the number of dead neurons. If δjnnj = δj Nj, that is all dead
cells are neurons, we can obtain βj.
Western Blot Analysis
Western bolt analysis was performed as described previously
(Luo et al., 2007). The primary antibodies were as follows: mouse
anti-nNOS (1:600; 610308; BD Biosciences), mouse anti-HDAC2
(1:2000; ab51832; Abcam) or mouse anti-GAPDH (1:2500; KC-
5G4; KangChen Bio-tech). Appropriate horseradish peroxidase-
linked secondary antibodies were used for detection by enhanced
chemiluminescence (Pierce).
HDAC2 Activity Assay
Histone deacetylase activity was assessed using a fluorometric
HDAC assay kit (EMD Millipore). For HDAC2-specific activity,
immunoprecipitation with the specific antibody was performed
before the assay as described previously (Guan et al., 2009; Luo
et al., 2014). Briefly, 0.5 µg of mouse anti-HDAC2 antibody
(Abcam) was added to the cellular lysates and incubated for
12 h at 4◦C. Then 20 µl of protein G-Agarose (Sigma-Aldrich)
was added and incubated on a tube rotator for 4 h at 4◦C.
Beads were centrifuged at 2500 × g and washed five times in
immunoprecipitation buffer (50 mM Tris-HCl, 150 mM NaCl,
5 mM EDTA, 0.5% NP40, pH 8.0, supplemented with 1 mM
PMSF). Finally, HDAC assay substrate was added to the beads
and incubated at 30◦C for 45 min, after which the reaction
was stopped and fluorescence was measured according to the
instructions of HDAC assay kit.
Recombinant Virus Infection
AD-HDAC2
The recombinant adenovirus, AD-HDAC2 or its control
AD-Null, was generated by GeneChem as we previously
reported (Luo et al., 2014). AD-HDAC2 overexpresses mouse
HDAC2 protein. Cultured NSCs were infected with AD-Null or
AD-HDAC2 containing 1.5 × 109 plaque-forming units/ml for
12 h in vitro (multiplicity of infection = 3). The adenovirus-
infected NSCs then proliferated or differentiated for 4 days. The
procedures concerning recombinant adenovirus were performed
following National Institutes of Health guidelines.
LV-HDAC2 shRNA
HDAC2 shRNA lentiviral particles (LV-HDAC2 shRNA; Santa
Cruz Biotechnology) are recommended for the inhibition of
HDAC2 expression in mouse cells. LV-Control shRNA (Santa
Cruz Biotechnology) or LV-HDAC2 shRNA containing 1.0× 106
infectious units/200 µl/vial was infected into cultured NSCs at
10 µl/well (24-well plate) when NSCs were passaged at 2 × 104
cells/cm2. Twelve hours later, the medium was fully changed
with fresh proliferation medium. The lentivirus-infected NSCs
proliferated for 4 days and were passaged for experiments. The
procedures concerning recombinant lentivirus were performed
following National Institutes of Health guidelines.
Statistical Analysis
Comparisons were made with one-way ANOVA followed by
Scheffe’s post hoc test. Data were presented as mean ± SEM.
Differences were considered significant when p< 0.05.
RESULTS
Endogenous nNOS Is Required for
Neuronal Differentiation of Embryonic
NSCs
To investigate the role of endogenous nNOS in neuronal
differentiation, we cultured embryonic NSCs from nNOS−/−
and WT mice. Monolayer-cultured NSCs proliferated for 24 h
and then were allowed to differentiate for 4 days. We found
that although nNOS gene knockout had much weak effect
on the percentage of astrocytes (GFAP+; Figures 1A,B), it
substantially reduced neuronal differentiation (β-III-Tubulin+)
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 March 2017 | Volume 11 | Article 66
fncel-11-00066 March 4, 2017 Time: 16:57 # 4
Jin et al. nNOS Regulates Neurogenesis via HDAC2
FIGURE 1 | Endogenous nNOS is required for neuronal differentiation of embryonic NSCs. The monolayer-cultured NSCs from nNOS–/– and WT embryonic
mice differentiated for 4 days and then were fixed for stain. (A) Statistical graph showing the ratio of GFAP+ astrocytes. (B) Representatives of GFAP-labeled cells.
(C) Statistical graph showing the ratio of β-III-Tubulin+ neurons. (D) Representatives of β-III-Tubulin+ cells. Nuclei were counterstained with Hoechst 33258. Scale
bars = 50 µm. Data are mean ± SEM (n = 3); ∗p<0.05 as compared with WT. GFAP, glial fibrillary acidic protein; nNOS–/–, gene knockout of neuronal nitric oxide
synthase; WT, wild-type.
(WT 20.39 ± 1.20% vs. nNOS−/− 11.21 ± 2.69%, p < 0.05;
Figures 1C,D), indicating that nNOS in NSCs is necessary for
neuronal differentiation in vitro.
Repression of nNOS Negatively
Regulates Neuronal Fate Commitment
The reduction of neuronal differentiation by nNOS gene
knockout could be due to some combination of decreased
proliferation of NSCs or progenitors, attenuated neuronal
survival, and/or inhibition of fate commitment by NSCs to
a neuronal lineage. First, we examined whether a decrease
in cell proliferation or survival might explain the reduced
number of neurons in nNOS-repression cultures. L-VNIO,
a highly selective inhibitor of nNOS (Babu and Griffith,
1998), was used to inhibit nNOS enzymatic activity. Cultures
were treated with 100 µM L-VNIO or vehicle for the later
2 days during the 4-day differentiation of monolayer-cultured
embryonic NSCs, immediately followed by fixation and staining
with antibody against β-III-Tubulin. Consistent with results of
nNOS gene knockout, we observed that L-VNIO did not affect
glial differentiation (Supplementary Figure S1), but remarkably
reduced the percentage of neurons (β-III-Tubulin+) at day
4 after differentiation (Control 20.83 ± 0.31% vs. L-VNIO
6.23 ± 0.40%, p < 0.001; Figures 2A,B). The reduction of
neuronal differentiation was not due to decreased proliferation
of progenitors, since L-VNIO did not inhibit cell proliferation
(Figures 2C,D). However, PI staining revealed that L-VNIO
significantly increased the apoptotic ratio of cells (PI+) (Control
3.48± 0.07% vs. L-VNIO 4.91± 0.15%, p< 0.01; Figures 2E,F).
Thus, cell apoptosis may contribute to the effect of L-VNIO on
decreased neurogenesis.
Does the repression of nNOS also inhibit progenitors to adopt
a neuronal fate? To address this question, we used a mathematical
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FIGURE 2 | Repression of nNOS negatively regulates neuronal fate commitment. Monolayer-cultured embryonic NSCs differentiated for 4 days and were
incubated with L-VNIO (100 µM) or vehicle during the later 2 days of differentiation. (A,B) L-VNIO inhibits neuronal differentiation. (A) Representatives of β-III-Tubulin+
neurons. (B) Statistical graph showing the ratio of β-III-Tubulin+ neurons. (C,D) L-VNIO has no effect on cell proliferation during NSCs differentiation. BrdU (2.5 µM)
was added during the later 2 days of differentiation to label the dividing cells. (C) Representatives of BrdU-labeled cells. (D) Statistical graph showing the ratio of
BrdU+ cells. (E,F) L-VNIO induces cell apoptosis. Live cultures were stained with PI which stains dead cells and Hoechst 33342 which stains live and dead cells.
(E) Representatives of PI+ nuclei (arrows). (F) Statistical graph showing the ratio of PI+ nuclei. (G) L-VNIO increases the rate of cell death (δ4). (H) L-VNIO decreases
the rate of conversion of progenitors to neurons (β4) even if all dead cells are neurons. (I) There are nestin+ progenitor cells throughout the differentiation stages. Cells
were fixed and stained for nestin at days 1, 2, 3, 4 after differentiation respectively. Data shown are mean ± SEM from three to five independent experiments in
parallel cultures; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. control. Scale bars = 50 µm [A,D,E,I (right)], 10 µm [I (left)]. BrdU, bromodeoxyuridine; L-VNIO,
N5-(1-imino-3-butenyl)-L-ornithine; PI, propidium iodide.
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FIGURE 3 | Upregulation of endogenous nNOS promotes neuronal differentiation. 50 mM KCl was treated during the first 12 (A) or 24 (A–H) hours, and
100 µM L-VNIO for the later 2 days of embryonic NSCs differentiation. (A) KCl increases nNOS expression in neural progenitor cells at day 1 after differentiation.
(B,C) KCl markedly increases the percentage of neurons at day 4 after differentiation. (B) Representatives of β-III-Tubulin+ neurons. (C) Statistical graph from data in
(B). (D,E) KCl induces cell apoptosis. Cell death was assessed by staining with Hoechst 33258 to visualize fragmented nuclei at day 4 after differentiation. (D) It
shows example images in Hoechst 33258 fluorescence. Arrows mark dying cells. (E) Statistical graph from data in (D). (F) Cultures treated with KCl exhibit notably
increased number of neurons at day 4 after differentiation. (G,H) The effect of KCl and L-VNIO on neuronal differentiation is abolished when nNOS is knocked out.
(G) Statistical graph showing the ratio of neurons. (H) Representatives of β-III-Tubulin+ neurons. Scale bars = 50 µm. Data are mean ± SEM (n = 3); ∗p < 0.05,
∗∗p < 0.01 as compared with control. GAPDH, glyceraldehyde phosphate dehydrogenase; L-VNIO, N5-(1-imino-3-butenyl)-L-ornithine; nNOS, neuronal nitric oxide
synthase.
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 March 2017 | Volume 11 | Article 66
fncel-11-00066 March 4, 2017 Time: 16:57 # 7
Jin et al. nNOS Regulates Neurogenesis via HDAC2
FIGURE 4 | HDAC2 down-regulation instructs embryonic NSCs to exit from the cell cycle and adopt a neuronal fate. (A) Immunoblots showing HDAC2
levels in the NSCs infected by LV-HDAC2 shRNA or LV-Control shRNA at day 4 after infection. (B,C) NSCs infected by LV-HDAC2 shRNA differentiate into notably
more neurons after differentiation for 4 days. (B) Representatives of β-III-Tubulin+ neurons. (C) Statistical graph from data in (B). (D) LV-HDAC2 shRNA inhibits NSCs
proliferation, quantified by cell counting. (E,F) LV-HDAC2 shRNA inhibits NSCs proliferation, quantified by BrdU incorporation. BrdU (10 µM) was introduced during
the last 2 h of the 24-h proliferation culture. (E) Statistical graph showing the percentage of BrdU+ cells. (F) Representatives of BrdU-labeled cells of the
monolayer-cultured NSCs. Scale bars = 50 µm. Data shown are mean values ± SEM from three experiments in parallel cultures; ∗p < 0.05 vs. LV-Control shRNA.
BrdU, bromodeoxyuridine; GAPDH, glyceraldehyde phosphate dehydrogenase; HDAC2, histone deacetylase 2; LV-Control shRNA, lentiviral vector containing
control shRNA; LV-HDAC2 shRNA, lentiviral vector containing shRNA of HDAC2.
description of neurogenesis, which is developed by Song et al.
(2002). During the process of quantitative description, we defined
δj as the death rate of all cells for the jth day in culture, and βj as
the conversion rate of progenitors (Tuj1−) to neurons (Tuj1+)
during that day. The death rate, δj, was measured by using PI dye
in live cultures and was given by the equation δj Nj = PIj+1 – PIj.
PIj is the number of dead cells present at the start of the j day
in culture and Nj is the total number of cells present at that
time. Consistent with results of Figures 2E,F, we found that the
death rate (δ4) is significantly higher in L-VNIO-treated cultures
(Control 0.024 ± 0.0007 vs. L-VNIO 0.054 ± 0.0033, p < 0.001;
Figure 2G). The rate of conversion of progenitors to neurons, βj,
was given by the equation n j+1 = nj + βj (Nj-nj) – δjnnj. nj is the
total number of neurons present at the start of the j day and δjn is
the death rate of neurons for the jth day. However, we could not
determine what fractions of the dead cells were neurons. If no
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FIGURE 5 | HDAC2 up-expression has no effect on NSC proliferation but reduces neuronal differentiation. (A) Immunoblots showing HDAC2 levels at day
4 after proliferation (top) or differentiation (bottom) of AD-Null- or AD-HDAC2-infected NSCs. (B) Statistical graph showing the number of cells of neurospheres at
day 4 after proliferation of AD-Null- or AD-HDAC2-infected NSCs. (C,D) AD-HDAC2 inhibits neuronal differentiation. AD-Null- or AD-HDAC2-infected NSCs
differentiated for 4 days and then were fixed for β-III-Tubulin staining. (C) Statistical graph showing the ratio of β-III-Tubulin+ neurons. (D) Example images of
β-III-Tubulin+ neurons. Scale bars = 50 µm. Data shown are mean values ± SEM from three experiments in parallel cultures; ∗∗p < 0.01 vs. AD-Null. AD-HDAC2,
adenovirus vector selectively expressing HDAC2; GAPDH, glyceraldehyde phosphate dehydrogenase; HDAC2, histone deacetylase 2.
neurons die, we can say L-VNIO decreases the rate of neuronal
fate commitment of NSCs. If all cells that die are neurons, that
is, δjnnj = δj Nj, we can obtain βj. As shown in Figure 2H,
L-VNIO leads to notably lower value of βj (j = 4) (Control
0.426 ± 0.05 vs. L-VNIO 0.136 ± 0.06, p < 0.05). In addition,
nestin labeling experiments showed that there are still neural
progenitor cells at day 4 after differentiation (Figure 2I). Taken
together, these results demonstrate that repression of nNOS
negatively regulates neuronal fate commitment of embryonic
NSCs.
Upregulation of Endogenous nNOS
Promotes Neuronal Differentiation
To examine the effect of nNOS upregulation on neuronal
differentiation, we incubated the cultures with 50 mM KCl
during the first 12 or 24 h of NSCs differentiation. Sasaki
et al. (2000) demonstrated that 50 mM KCl induces nNOS
expression in cortical neurons. Our results showed that 50 mM
KCl for 24 h clearly increased nNOS expression at day 1 after
differentiation (Figure 3A), when almost all cells are nestin+
neural progenitors (Figure 2I). Treatment with 50 mM KCl for
the first 24 h significantly promoted neuronal differentiation at
day 4 after differentiation. The ratio of β-III-Tubulin+ neurons
in KCl-treated cultures was 24.95 ± 2.07%, compared with
14.07 ± 1.03% in control (Figures 3B,C, p < 0.01). Moreover,
50 mM KCl markedly induced cell apoptosis (Figures 3D,E). The
apoptotic effect was not mediated by nNOS since nNOS gene
knockout did not abolish the effect (Supplementary Figure S2).
If all dead cells are astrocytes, the data of increased neuronal
ratio in KCl-treated cultures might be superficial. We then
counted the number of β-III-Tubulin+ cells, which was proved
to be much higher in KCl-treated cultures (Figure 3F). To
confirm that nNOS mediates the effect of KCl and L-VNIO
on neuronal differentiation, we treated nNOS−/− cells with
50 mM KCl for the first 24 h or 100 µM L-VNIO for the
later 2 days of 4-day differentiation. As shown in Figures 3G,H,
nNOS gene knockout abolished the effect of KCl and L-VNIO
on neuronal differentiation. These findings collectively indicate
that upregulation of endogenous nNOS promotes neuronal
differentiation.
HDAC2 Mediates the Role of nNOS in
Regulating the Fate of Embryonic NSCs
To explore the molecular mechanisms underlying the regulation
of NSC fate by nNOS, we investigated the role of HDAC2. To
regulate HDAC2 specifically, we generated a lentiviral vector that
contains shRNA of HDAC2 and named it LV-HDAC2 shRNA.
LV-HDAC2 shRNA effectively infected NSCs and significantly
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FIGURE 6 | Repression of nNOS negatively regulates differentiation of embryonic NSCs into neurons by upregulation of HDAC2. (A,B) HDAC2 levels
(A) and enzymatic activity (B) in cultures treated with 100 µM L-VNIO or vehicle for the first 24 h during differentiation. (C–E) HDAC2 down-regulation rescues
L-VNIO-induced neuronal differentiation reduction. 100 µM L-VNIO or vehicle was treated for the later 2 days during the 4-day differentiation of LV-HDAC2 shRNA-
or LV-Control shRNA-infected NSCs. (C) Bar graph showing the number of newborn neurons. (D) Bar graph showing the percentage of newborn neurons.
(E) Representatives of β-III-Tubulin+ neurons. Scale bars = 50 µm. Data are mean ± SEM (n = 3); ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. GAPDH, glyceraldehyde
phosphate dehydrogenase; HDAC2, histone deacetylase 2; LV-Control shRNA, lentiviral vector containing control shRNA; LV-HDAC2 shRNA, lentiviral vector
containing shRNA of HDAC2; L-VNIO, N5-(1-imino-3-butenyl)-L-ornithine.
decreased HDAC2 expression (Figure 4A). LV-HDAC2 shRNA-
infected NSCs gave rise to significantly increased numbers of
neurons (Figures 4B,C) but exhibited a decrease in their own
proliferation (Figures 4D–F), suggesting that HDAC2 down-
regulation instructs NSCs to exit from the cell cycle and adopt
a neuronal fate. To further confirm the effect of HDAC2 in
NSCs on neurogenesis, we infected NSCs with an adenovirus
vector selectively expressing HDAC2 (AD-HDAC2) for 12 h,
then AD-HDAC2 increased HDAC2 expression at day 4 after
proliferation (Figure 5A, top) or differentiation (Figure 5A,
bottom). Unexpectedly, AD-HDAC2 had no effect on NSC
proliferation (Figure 5B), but significantly decreased neuronal
differentiation (Figures 5C,D). Both LV-HDAC2 shRNA and
AD-HDAC2 did not affect cell apoptosis (data not shown).
Thus, HDAC2 negatively regulates neuronal fate commitment of
embryonic NSCs.
Next, we asked whether nNOS could regulate HDAC2,
thereby affecting the fate of NSCs. We planted neurospheres
in polyornithine-coated cell culture dishes in differentiation
medium and immediately treated cells with 100 µM L-VNIO
or vehicle for 24 h. We found that L-VNIO significantly
increased HDAC2 expression and enzymatic activity at day 1 after
differentiation (Figures 6A,B). To determine whether HDAC2
upregulation mediates the role of L-VNIO in inhibition of fate
commitment by NSCs to a neuronal lineage, we treated cultures
with 100 µM L-VNIO or vehicle for the later 2 days during the 4-
day differentiation of LV-HDAC2 shRNA- or LV-Control shRNA-
infected NSCs. HDAC2 down-regulation rescued L-VNIO-
induced neuronal differentiation reduction (Figures 6C–E).
Together, nNOS repression negatively regulates neuronal fate
commitment by upregulation of HDAC2 in progenitor cells.
HDAC2 Mediates the Role of nNOS in
Regulating the Fate of Adult NSCs
To determine whether HDAC2 is a mediator for the regulation
of NSC fate by nNOS, we cultured adult NSCs isolated from
the hippocampus of 2-month-old male mice. These adult
NSCs express nestin--- a marker of neural stem/progenitor
cells, actively proliferate and differentiate into neurons (β-
III-Tubulin+) and astrocytes (GFAP+) (Figure 7A). L-VNIO
(100 µM) was added to the cultures at the start of day 3
during differentiation of monolayer-cultured adult NSCs. After
48 h, L-VNIO significantly inhibited neuronal differentiation
(Figure 7B). Furthermore, 100 µM L-VNIO added for the
first 24 h during differentiation dramatically increased HDAC2
expression and enzymatic activity at day 1 after differentiation
(Figures 7C,D). LV-HDAC2 shRNA-infected adult NSCs
differentiated into more neurons, and the negative effect of
L-VNIO on neuronal differentiation was abolished in LV-
HDAC2 shRNA-infected adult NSCs (Figures 7E,F), suggesting
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FIGURE 7 | HDAC2 mediates the role of nNOS in regulating the fate of adult NSCs. (A) Identification of cultured adult NSCs. Single-cell suspensions were
seeded on polyornithine/laminin-coated coverslips, cultured as a monolayer for 24 h, and then fixed for nestin staining. At least 92% cells were nestin+ NSCs. In
addition, cells were monolayer-cultured in the presence of 10 µM BrdU for 24 h and fixed for stain, and most cells were BrdU+ labeled. These cells could differentiate
into β-III-Tubulin+ neurons and GFAP+ astrocytes after differentiation for 4 days. (B) Monolayer-cultured adult NSCs treated with 100 µM L-VNIO during the later
2 days of 4-day differentiation exhibit a marked decrease of neuronal differentiation. Immunoblots showing HDAC2 levels (C) and bar graph showing HDAC2 activity
(D) in cultures treated with 100 µM L-VNIO or vehicle for the first 24 h during differentiation. (E,F) HDAC2 down-regulation rescues L-VNIO-induced neuronal
differentiation reduction. 100 µM L-VNIO or vehicle was treated for the later 2 days during the 4-day differentiation of LV-HDAC2 shRNA- or LV-Control
shRNA-infected adult NSCs. (E) Bar graph showing the percentage of newborn neurons. (F) Representatives of β-III-Tubulin+ neurons. Scale bars = 50 µm. Data
are mean ± SEM (n = 3); ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. BrdU, bromodeoxyuridine; GAPDH, glyceraldehyde phosphate dehydrogenase; GFAP, glial fibrillary
acidic protein; HDAC2, histone deacetylase 2; LV-Control shRNA, lentiviral vector containing control shRNA; LV-HDAC2 shRNA, lentiviral vector containing shRNA of
HDAC2; L-VNIO, N5-(1-imino-3-butenyl)-L-ornithine.
that HDAC2 upregulation mediates the effect of nNOS
repression on inhibiting differentiation of adult NSCs into
neurons.
DISCUSSION
In this study, we have examined the role of endogenous nNOS
in neurogenesis by nNOS gene knockout and pharmacological
intervention. We demonstrated that endogenous nNOS
promotes neuronal differentiation. Using a quantitative
approach, we showed that nNOS in neural progenitors instructs
neuronal fate commitment. We also explored the molecular
mechanism underlying and established that the changes of
HDAC2 expression and enzymatic activity may be critical.
Neuronal nitric oxide synthase, mainly responsible for NO
production in central nervous system, has been implicated in the
regulation of various physiological and pathological functions,
such as neurogenesis and neurodegeneration (Zhang and Snyder,
1995; Boehning and Snyder, 2003). In our previous studies,
we found that NSC-derived nNOS is located in nucleus and
expressed at a much lower level than that in neurons (Luo
et al., 2010). The nuclei localization and lower expression
of nNOS in NSCs induce that NO hardly diffuses to the
outside of NSCs and may act by nuclear signaling molecule.
However, neuron-derived NO can diffuse into the cytoplasms
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of neighboring cells and probably acts via cytoplasmic signaling
molecule. The differences raise a possibility that different
sources of NO play different roles. We recently proved that
neuron-derived NO negatively regulates neurogenesis under
physiological and pathological conditions (Luo et al., 2010,
2014). In the present study, we found that NSCs lacking
nNOS gene differentiated into fewer neurons, suggesting a
positive role of endogenous nNOS in neurogenesis. Did the
nNOS instruct progenitors to adopt a neuronal fate? Using a
quantitative approach, we separated instructive effects from other
possibilities, including cell proliferation and survival. Our results
showed that nNOS in progenitors was required for neuronal
fate commitment and cell survival, but not required for cell
proliferation probably due to the much low rate of proliferation
during the later 2 days of differentiation (Supplementary
Figure S3).
A main part of our research is to explore the mechanism
underlying the role of endogenous nNOS in neurogenesis. HDAC
inhibition mediated by non-selective inhibitors has been shown
to promote neurogenesis (Hsieh et al., 2004b; Balasubramaniyan
et al., 2006). However, non-selective blockade of HDACs has
been reported to cause a range of untoward effects (Bruserud
et al., 2007). Thus, one specific HDAC family member involved
in neurogenesis may provide a safer strategy. Here we transfected
NSCs with LV-HDAC2 shRNA or AD-HDAC2, and confirmed
that HDAC2 negatively regulates neuronal fate commitment
of NSCs. As a nuclear signaling molecule (Walkinshaw et al.,
2008), HDAC2 may mediate the role of endogenous nNOS. Our
findings proved the notion and indicated that nNOS-mediated
instruction of fate commitment by NSCs to a neuronal lineage
is predominantly due to the reduction of HDAC2 expression
and enzymatic activity. However, HDAC2 impossibly mediates
nNOS-required cell survival because both LV-HDAC2 shRNA
and AD-HDAC2 do not induce cell apoptosis. This is why
nNOS repression also decreases neuronal ratio in LV-HDAC2
shRNA-infected cultures (Figures 6C,D, 7E). Not only do
these results reveal important functions of HDAC2 in nNOS-
required neurogenesis, they also suggest that HDAC2 could be a
primary target for therapeutic intervention of neurodegenerative
disorders since selective increase of nNOS in NSCs but not in
neurons is a great challenge.
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